** Shares of Miromatrix Medical MIRO.O more than triple to
$3.4 premarket
** United Therapeutics UTHR.O says it will acquire the
life sciences company for about $91 million or $3.25 per share
in cash
** Deal represents a 212.5% premium to MIRO's last close on
Friday
** The deal helps expand UTHR's organ manufacturing program
with MIRO's platform used to develop bioengineered organs
composed of human cells - UTHR
** Transaction is not subject to any financing condition and
is expected to close in the fourth quarter of 2023 - UTHR
** Up to last close, MIRO shares down ~65% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))